Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Protein Structure, Secondary
Uranium
Semel, Jeffrey
Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.
Vascular smooth muscle cell differentiation in human cerebral vascular malformations.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vascular smooth muscle cell differentiation in human cerebral vascular malformations.
Vascular smooth muscle cell differentiation in human cerebral vascular malformations. Neurosurgery. 2001 Sep; 49(3):671-9; discussion 679-80.
View in:
PubMed
subject areas
Actins
Adolescent
Adult
Antibodies
Cell Culture Techniques
Cell Differentiation
Culture Techniques
Female
Humans
Immunohistochemistry
Intracranial Arteriovenous Malformations
Male
Middle Aged
Muscle, Smooth, Vascular
Myosin Heavy Chains
Smooth Muscle Myosins
authors with profiles
Issam Awad